Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Pleural Effusion Treatment Market Share, Size, Trends, Analysis, Growth, Forecast: By Disease Type: Transudate Effusion, Exudate Effusion; By Treatment: Tube Thoracostomy (Chest Tube), Pleurodesis, Thoracentesis, Pleural decortication, Pleural drain, Others; By End Use; Regional Analysis; Competitive Landscape; 2023-2028

Global Pleural Effusion Treatment Market Outlook

The global pleural effusion treatment market is expected to grow at a CAGR of 4.90% between 2023 and 2028. Key market drivers are rise in cases of pleural effusion, increasing treatment facilities, and spreading awareness.

 

Key Trends in the Market

Pleural effusion, also known as ‘water on the lungs’ is an abnormal lung condition in which excess fluid builds up outside the lungs between the layers of pleura. They are usually caused by conditions such as pulmonary embolisms, congestive heart failure, pneumonia, and cancer. Some of the common pleural effusion treatments include pleurodesis, drainage catheter placement, surgery, and therapeutic thoracentesis. 

 

  • Occurrences of pleural effusion are rapidly increasing because of growing prevalence of lung tumours, further fuelled by cigarette smoking. Other conditions such as blood vessel blockage, lung injuries, and congestive heart failures are also increasing the cases for pleural effusion increasing the demand for pleural effusion treatment.
  • Major market players are carrying out research and development activities, launching new products to treat pleural effusions more easily and effectively.
  • Increased awareness regarding pleural effusion and its symptoms is encouraging patients to seek out treatment earlier, supplementing the demand for the pleural effusion treatment market.

 

Market Analysis

Based on disease type, the market can be bifurcated into transudate effusion and exudate effusion. On the basis of treatment, the market is divided into tube thoracostomy (chest tube), pleurodesis, thoracentesis, pleurodesis, thoracentesis, pleural decortication, and pleural drain, among others. Based on end use, the market is categorised into hospitals, specialised clinics, and ambulatory surgical centres, among others. By region, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. 

 

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global pleural effusion treatment market covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.

 

  • B. Braun Melsungen AG
  • Becton, Dickinson, and Company
  • Biometrix
  • Rocket Medical plc
  • ICU Medical Inc.
  • Others

 

Market Share by Disease Type

Transudative effusion disease type has accounted for a large share in the pleural effusion treatment market because of the increasing prevalence of congestive heart failures, cirrhosis, and kidney failure that can lead to transudative effusion. Transudative is caused by a hydrostatic imbalance with a build-up of watery fluid outside the lungs. Increasing prevalence of such conditions are likely to result in an increase in transudative effusion cases. 

 

Exudate effusions are caused by increased capillary permeability that leads to leakage of cell, protein, and other serum constituent. Conditions that cause exudative effusion are tuberculosis, pneumonia, or diseases causing pleuro-renal syndromes. Demand for pleural effusion treatment for exudate effusions tends to vary depending upon region, and the prevalence of causing conditions. 

 

Market Share by Region

North America accounted for a large share in the pleural effusion treatment market because of rising prevalence of the pleural effusion and rising cases of heart related diseases in the North American region. Furthermore, rising healthcare expenditure, increase in geriatric populations, and robust healthcare infrastructure in countries such as the United States have supported the growth of the region in the overall market. 

 

Asia Pacific is also expected to observe a significant growth in the market for pleural effusion treatment owing to increasing cases of respiratory disorder and lung cancer. With advancements in healthcare technology used in the region, multiple treatment options for pleural effusion are becoming increasingly accessible in the Asia Pacific.

 

Competitive Landscape

Biometrix was founded in 1986 and is based in Yerushalayim, Israel. It is a medical device company that develops and manufactures premium quality medical devices in order to meet the medical demands of various critical care procedures in various industries such as biotechnology, pharmaceuticals, and medical device industry. 

 

Rocket Medical plc is a medical equipment manufacturing company that designs and manufactures single use medical devices for clinical use in various areas such as diagnostic machines, reproductive medicines, pulmonary therapy, obstetrics, and ascites drainage. It has its headquarter in Washington in the United Kingdom and was founded in 1964. 

 

ICU Medical Inc. was established in 1984 and is headquartered in California, United States. It designs and manufactures medical technologies and distributes them globally for oncology, critical care, and vascular therapy. They believe in connecting healthcare providers and patients with the help of safe, life enhancing, and life saving devices.   

 

Other market players include B. Braun Melsungen AG, and Becton, Dickinson, and Company, among others.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Disease Type
  • Treatment
  • End Use
  • Region
Breakup by Disease Type
  • Transudate Effusion
  • Exudate Effusion
Breakup by Treatment
  • Tube Thoracostomy (Chest Tube)
  • Pleurodesis
  • Thoracentesis
  • Pleural decortication
  • Pleural drain
  • Others
Breakup by End Use
  • Hospitals
  • Specialised Clinics
  • Ambulatory Surgical Centres
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biometrix
  • Rocket Medical plc
  • ICU Medical Inc.
  • Others

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Pleural Effusion Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Pleural Effusion Treatment Historical Market (2018-2022) 
    8.3    Global Pleural Effusion Treatment Market Forecast (2023-2028)
    8.4    Global Pleural Effusion Treatment Market by Disease Type
        8.4.1    Transudate Effusion
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    Exudate Effusion
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
    8.5    Global Pleural Effusion Treatment Market by Treatment
        8.5.1    Tube Thoracostomy (Chest Tube)
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Pleurodesis
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Thoracentesis 
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
        8.5.4    Pleural decortication
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2018-2022)
            8.5.4.3    Forecast Trend (2023-2028)
        8.5.5    Pleural drain
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2018-2022)
            8.5.5.3    Forecast Trend (2023-2028)
        8.5.6    Others
    8.6    Global Pleural Effusion Treatment Market by End Use
        8.6.1    Hospitals 
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022)
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Specialised Clinics
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022)
            8.6.2.3    Forecast Trend (2023-2028)
        8.6.3    Ambulatory Surgical Centres
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2018-2022)
            8.6.3.3    Forecast Trend (2023-2028)
        8.6.4    Others
    8.7    Global Pleural Effusion Treatment Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2018-2022)
        9.1.2    Forecast Trend (2023-2028)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2018-2022)
        9.2.2    Forecast Trend (2023-2028)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2018-2022)
        9.3.2    Forecast Trend (2023-2028)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2018-2022)
        9.4.2    Forecast Trend (2023-2028)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2018-2022)
        9.5.2    Forecast Trend (2023-2028)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    B. Braun Melsungen AG 
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Becton, Dickinson and Company
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Biometrix
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Rocket Medical plc 
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    ICU Medical Inc.
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Others
12    Industry Events and Developments

 

List of Key Figures and Tables

1.    Global Pleural Effusion Treatment Market: Key Industry Highlights, 2017 and 2027
2.    Global Pleural Effusion Treatment Historical Market: Breakup by Disease Type (USD Million), 2018-2022
3.    Global Pleural Effusion Treatment Market Forecast: Breakup by Disease Type (USD Million), 2023-2028
4.    Global Pleural Effusion Treatment Historical Market: Breakup by Treatment (USD Million), 2018-2022
5.    Global Pleural Effusion Treatment Market Forecast: Breakup by Treatment (USD Million), 2023-2028
6.    Global Pleural Effusion Treatment Historical Market: Breakup by End Use (USD Million), 2018-2022
7.    Global Pleural Effusion Treatment Market Forecast: Breakup by End Use (USD Million), 2023-2028
8.    Global Pleural Effusion Treatment Historical Market: Breakup by Region (USD Million), 2018-2022
9.    Global Pleural Effusion Treatment Market Forecast: Breakup by Region (USD Million), 2023-2028
10.    North America Pleural Effusion Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
11.    North America Pleural Effusion Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
12.    Europe Pleural Effusion Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
13.    Europe Pleural Effusion Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
14.    Asia Pacific Pleural Effusion Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
15.    Asia Pacific Pleural Effusion Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
16.    Latin America Pleural Effusion Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
17.    Latin America Pleural Effusion Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
18.    Middle East and Africa Pleural Effusion Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
19.    Middle East and Africa Pleural Effusion Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
20.    Global Pleural Effusion Treatment Market Structure

Key Questions Answered in the Report

The global market for pleural effusion treatment is expected to grow at a CAGR of 4.90% between 2023 and 2028.

The major market drivers include rise in prevalence of pleural effusion, increasing investments, and growing awareness regarding signs and symptoms of pleural effusion.

The key trends of the market are development activities by key players, expansion of healthcare and treatment infrastructure in developing nations, and early treatment of pleural effusion.

Key market players include B. Braun Melsungen AG, Becton, Dickinson, and Company, Biometrix, Rocket Medical plc, and ICU Medical Inc., among others.

Pleural effusion, also known as ‘water on the lungs’ is an abnormal lung condition in which excess fluid builds up outside the lungs between the layers of pleura.

Pleural effusion can be caused by pulmonary embolism, congestive heart failure, pneumonia, and cancer, among others.

The global pleural effusion treatment market is segmented based on disease type, treatment, end use, and region.

The various pleural effusion treatments include tube thoracostomy (chest tube), pleurodesis, thoracentesis, pleurodesis, thoracentesis, pleural decortication, and pleural drain, among others.

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER